Legacy Edge Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Sell
5,944
-125
-2% -$29.1K 0.14% 82
2026
Q1
$1.48M Sell
6,069
-63
-1% -$14.7K 0.16% 76
2025
Q4
$1.27M Sell
6,132
-143
-2% -$28.3K 0.14% 84
2025
Q3
$1.16M Sell
6,275
-294
-4% -$50.4K 0.14% 85
2025
Q2
$1M Buy
6,569
+74
+1% +$11.4K 0.13% 83
2025
Q1
$1.08M Buy
6,495
+347
+6% +$54.3K 0.17% 70
2024
Q4
$881K Sell
6,148
-40
-0.6% -$6.2K 0.14% 79
2024
Q3
$1M Sell
6,188
-90
-1% -$14.3K 0.16% 74
2024
Q2
$918K Buy
6,278
+207
+3% +$30.8K 0.17% 70
2024
Q1
$960K Sell
6,071
-88
-1% -$14K 0.2% 66
2023
Q4
$965K Buy
+6,159
New +$944K 0.22% 64

Other funds holding JNJ

Legacy Edge Advisors's JNJ Position: Q2 2026 in Review

Legacy Edge Advisors reduced its Johnson & Johnson (JNJ) stake by 2.1% in Q2 2026, selling an estimated $29.1K and leaving 5,944 shares worth $1.51M. The position accounts for 0.14% of the portfolio, ranked #82.

Legacy Edge Advisors first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,695 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Legacy Edge Advisors held 5,944 shares of Johnson & Johnson worth $1.51M as of Q2 2026.
  • Legacy Edge Advisors sold 125 Johnson & Johnson shares in Q2 2026, an estimated $29.1K.
  • Johnson & Johnson made up 0.14% of Legacy Edge Advisors's portfolio in Q2 2026, its #82 holding.
  • Legacy Edge Advisors first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,695 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Legacy Edge Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.